These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 69003)

  • 1. In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells.
    Gillis S; Smith KA
    J Exp Med; 1977 Aug; 146(2):468-82. PubMed ID: 69003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ; Howe ML
    J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro induction of cell-mediated immunity to murine leukemia cells. II. cytotoxic activity in vitro and tumor-neutralizing capacity in vivo of anti-leukemia cytotoxic lymphocytes generated in macrocultures.
    Kedar E; Schwartzbach M; Raanan Z; Hefetz S
    J Immunol Methods; 1977; 16(1):39-58. PubMed ID: 68086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The detection of a spleen focus-forming virus neoantigen by lymphocyte-mediated cytolysis.
    Gillis S; Gillis AE; Smith KA
    J Exp Med; 1978 Jul; 148(1):18-31. PubMed ID: 78957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Friend murine leukemia virus and spleen focus-forming virus expression in highly malignant interferon-sensitive and interferon-resistant Friend leukemia cells.
    Oppi C; Fiorucci G; Ferrantini M; Battistini A; Belardelli F
    Virology; 1986 Apr; 150(2):390-401. PubMed ID: 2421480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus.
    Plata F; Lilly F
    J Exp Med; 1979 Nov; 150(5):1174-86. PubMed ID: 91655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. I. Virus replication in lymphocytes infected with Friend virus and cultures in diffusion chambers in vivo.
    Cerny J; Fistel SH; Hensgen PA
    Int J Cancer; 1976 Aug; 18(2):176-88. PubMed ID: 182644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors.
    Chen W; Qin H; Chesebro B; Cheever MA
    J Virol; 1996 Nov; 70(11):7773-82. PubMed ID: 8892898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Friend erythroleukemia antigen. A viral antigen specified by spleen focus-forming virus and differentiation antigen controlled by the Fv-2 locus.
    Risser R
    J Exp Med; 1979 May; 149(5):1152-67. PubMed ID: 448285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface antigens of radiation leukemia virus-induced BALB/c leukemias defined by syngeneic cytotoxic T lymphocytes.
    Kaneko Y; Oettgen HF; Obata Y; Nakayama E
    Jpn J Cancer Res; 1989 Mar; 80(3):257-64. PubMed ID: 2542207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired generation of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in mice experimentally infected with MuLV.
    Coppola MA; Green WR; Rich RF
    Viral Immunol; 1996; 9(2):107-19. PubMed ID: 8822627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. II. Infections of B and T cells with Friend virus complex indiffusion chambers and in vitro: effect of polyclonal mitogens.
    Cerny J; Hensgen PA; Fistel SH; Demler LM
    Int J Cancer; 1976 Aug; 18(2):189-96. PubMed ID: 1085288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens.
    Green WR; Nowinski RC; Henney CS
    J Exp Med; 1979 Jul; 150(1):51-66. PubMed ID: 109575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of cytotoxic lymphocytes in mixed lymphocyte reactions. I. Specificity of the effector cells.
    Forman J; Möller G
    J Exp Med; 1973 Sep; 138(3):672-85. PubMed ID: 4269560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the mechanisms for the induction of in vivo tumor immunity. II. Distribution and homing of cytotoxic effector and precursor cells.
    Ting CC
    J Natl Cancer Inst; 1978 Feb; 60(2):437-44. PubMed ID: 304488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.